The need for faster access to new drugs is resulting in an increased demand for IoT technology in order to improve speed to market and data accuracy for clinical trials. As more contract research organizations (CROs) and pharmaceutical companies are looking to decentralize their clinical trials, outsourcing things such as hardware procurement, wireless connectivity, configuration, kitting, and deployment services is becoming increasingly necessary. When selecting a vendor for decentralized clinical trials, regulatory compliance should be a primary concern and top priority.
Download the eBook “Regulatory Compliance and Clinical Trial Vendor Selection” to learn: